Abnormal CHD8 Function Leads to Altered Brain Development and Associated ASD Social Behaviors
Nancy Yang
Introduction. Autism spectrum disorders (ASD) include a group of neurodevelopmental disorders characterized by core symptoms of social interaction deficits and restrictive, repetitive patterns of behaviors.2 Many ASD risk genes have been identified, and a common ASD-related gene mutation affects the chromodomain helicase DNA-binding protein 8 (CHD8).1,3,4 CHD8 has many roles, including proper neuronal development and connectivity. Indeed, abnormal neuronal migration, functional connectivity, and myelination have all been identified in ASD study models.1,2,3,4 Current treatments focus on managing symptoms through behavioral interventions, and no medications directly treat the two core ASD symptoms.1,2 Oxytocin may prove to be a potential treatment for a subset of ASD patients with known Chd8 mutations.5,6,7 Methods. Fluorescently labeled cortical neurons of Chd8 heterozygous mutant mice were visualized during pre- and postnatal development.1 rsfMRI was used to examine connectivity among various brain areas of Chd8 mutant mice, and social interactions were assessed.2 DTI analysis of mice having dysfunctional Chd8 in their oligodendrocytes found correlations between functional connectivity and social behaviors.3 Spontaneous excitatory postsynaptic currents (sEPSCs) and miniature inhibitory postsynaptic currents (mIPSCs) were also measured via electrophysiology in medium spiny neurons in the nucleus accumbens of Chd8 mutant mice.4 Chd8 mutant mice were administered oxytocin intraperitoneally.5 In two clinical trials, ASD patients were given intranasal oxytocin.6,7 Results. Neuronal migration was delayed in the brains of Chd8 mutant mice, although the process eventually caught up.1 Overconnectivity between the auditory cortex and other cortical areas was seen in Chd8 mutant mice, which may contribute to auditory processing deficits and over-responsivity to sensory stimuli—behaviors seen in ASD.2 DTI analysis revealed altered functional connectivity, which was associated with brain structural and behavioral changes.3 Electrophysiology studies showed increased sEPSC and mIPSC frequency and/or amplitude in Chd8 mutant mice, suggesting that local decrease of inhibitory transmission may contribute to enhanced excitatory inputs onto MSNs.4 In Chd8 mice, oxytocin restored plasma oxytocin levels and allowed them to overcome anxiety-like behaviors and correct social preferences.5 In ASD individuals, there were slight improvements in social functioning, and whole brain analyses revealed reduced amygdala connectivity, particularly to the cortical regions of the “social brain.”6,7 Conclusions. Oxytocin is a potentially useful therapeutic for a subset of individuals with ASD; however, it remains to be determined whether those most helped by oxytocin have Chd8-related gene mutations. To better guide therapeutic development, future clinical studies should consider mutations in Chd8 as a potential factor in therapeutic response to oxytocin.
- Xu Q, Liu YY, Wang X, et al. Autism-associated CHD8 deficiency impairs axon development and migration of cortical neurons. Mol Autism. 2018;9:65. Published 2018 Dec 19. doi:10.1186/s13229-018-0244-2
- Suetterlin P, Hurley S, Mohan C, et al. Altered Neocortical Gene Expression, Brain Overgrowth and Functional Over-Connectivity in Chd8 Haploinsufficient Mice. Cereb Cortex. 2018;28(6):2192-2206. doi:10.1093/cercor/bhy058
- Kawamura A, Abe Y, Seki F, et al. Chd8 mutation in oligodendrocytes alters microstructure and functional connectivity in the mouse brain. Mol Brain. 2020;13(1):160. Published 2020 Nov 23. doi:10.1186/s13041-020-00699-x
- Platt RJ, Zhou Y, Slaymaker IM, et al. Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits. Cell Rep. 2017;19(2):335-350. doi:10.1016/j.celrep.2017.03.052
- Cherepanov SM, Gerasimenko M, Yuhi T, et al. Oxytocin ameliorates impaired social behavior in a Chd8 haploinsufficiency mouse model of autism. BMC Neurosci. 2021;22(1):32. Published 2021 May 1. doi:10.1186/s12868-021-00631-6
- Parker KJ, Oztan O, Libove RA, et al. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism. Proc Natl Acad Sci U S A. 2017;114(30):8119-8124. doi:10.1073/pnas.1705521114
- Alaerts K, Bernaerts S, Prinsen J, Dillen C, Steyaert J, Wenderoth N. Oxytocin induces long-lasting adaptations within amygdala circuitry in autism: a treatment-mechanism study with randomized placebo-controlled design. 2020;45(7):1141-1149. doi:10.1038/s41386-020-0653-8